David A. Bond
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 37
- Genetics 29
- Chronic Lymphocytic Leukemia Research 29
- Co-authors
- Jennifer A. Woyach (10 shared papers)Samantha Jaglowski (11 shared papers)Kami J. Maddocks (33 shared papers)Nathan Denlinger (7 shared papers)Mark A. Reiley (1 shared paper)Lapo Alinari (16 shared papers)Ying Huang (13 shared papers)Michael R. Grever (7 shared papers)
- Journals
- Blood (11 papers)Journal of Clinical Oncology (6 papers)Blood Advances (5 papers)Hematological Oncology (4 papers)Transplantation and Cellular Therapy (2 papers)
- Partner nations
- United StatesCanadaItaly
In The Last Decade
David A. Bond
45 papers receiving 514 citations
Peers
Comparison fields: 5 of 48
- Genetics 236
- Pathology and Forensic Medicine 239
- Oncology 183
- Hematology 63
- Immunology 84
Countries citing papers authored by David A. Bond
This map shows the geographic impact of David A. Bond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Bond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Bond more than expected).
Fields of papers citing papers by David A. Bond
This network shows the impact of papers produced by David A. Bond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Bond. The network helps show where David A. Bond may publish in the future.
Co-authors
The 25 scholars most cited alongside David A. Bond, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 103 | |
| 2 | 2021 | 67 | |
| 3 | 1984 | 58 | |
| 4 | 2020 | 36 | |
| 5 | 2021 | 31 | |
| 6 | 2020 | 17 | |
| 7 | 2020 | 16 | |
| 8 | 2022 | 16 | |
| 9 | 2021 | 15 | |
| 10 | 2023 | 15 | |
| 11 | 2019 | 15 | |
| 12 | 2020 | 13 | |
| 13 | 2022 | 12 | |
| 14 | Bruton tyrosine kinase inhibitors for the treatment of mantle cell lymphoma: review of current evidence and future directions. | 2019 | 10 |
| 15 | 2022 | 9 | |
| 16 | 2021 | 9 | |
| 17 | 2023 | 9 | |
| 18 | 2019 | 8 | |
| 19 | 2024 | 7 | |
| 20 | 2022 | 7 |
About David A. Bond
David A. Bond is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Pulmonary and Respiratory Medicine and Neurology, having authored 51 papers that have together received 529 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (37 papers), Chronic Lymphocytic Leukemia Research (29 papers), Viral-associated cancers and disorders (9 papers), CAR-T cell therapy research (9 papers), CNS Lymphoma Diagnosis and Treatment (6 papers), Advanced Breast Cancer Therapies (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Cutaneous lymphoproliferative disorders research (3 papers). The work is most often cited by research in Genetics (236 citations), Pathology and Forensic Medicine (239 citations), Oncology (183 citations), Hematology (63 citations) and Immunology (84 citations). David A. Bond has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Jennifer A. Woyach, Samantha Jaglowski, Kami J. Maddocks, Nathan Denlinger, Mark A. Reiley, Lapo Alinari, Ying Huang, Michael R. Grever, Seema A. Bhat and John C. Byrd. Their work appears in journals such as Blood, Journal of Clinical Oncology, Blood Advances, Hematological Oncology and Transplantation and Cellular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.